TREA

97433023 - TILRAY MEDICAL

Follow

Information

  • Trademark
  • 97433023
  • Serial Number
    97433023
  • Filing Date
    May 27, 2022
    3 years ago
  • Transaction Date
    April 23, 2025
    a month ago
  • Status Date
    April 04, 2025
    a month ago
  • Location Date
    April 04, 2025
    a month ago
  • Status Code
    653
  • Current Location
    TMO LAW OFFICE 113
    Employee Name
    KEELEY, ALISON
  • Attorney Docket Number
    81844.0006
    Attorney Name
    Cynthia A. Moyer
    Law Office Assigned Location Code
    M40
  • Owners
Information
Mark Drawing Code
3
Mark Identification
TILRAY MEDICAL
Case File Statements
  • GS0411: Providing entertainment information in the field of cannabis culture via a website; providing news via a website in the nature of current event reporting in the field of cannabis and cannabis culture; providing educational information in the field of cannabis-themed cultural events and festivals via a website
  • DM0000: The mark consists of a stylized sideways "V" with three sun rays radiating out from the center of the "V" and to the right of the "V" the stylized word TILRAY above the word MEDICAL.
  • GS0051: Cannabis related products, namely, medicated oils, salves, tinctures, tablets and capsules, each containing cannabis for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oils, salves, tinctures, tablets and capsules each containing resins and oils derived from cannabis for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes containing cannabis for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes containing derivatives of cannabis, namely, resins and oils for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; medicated topical skin creams, bar and liquid soaps, bath additives, bath herbs, bath oils, body creams, body oils, face and body lotions, face and body milk, face lotion, and skin care preparations each containing derivatives of cannabis, for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; personal sexual lubricants; transdermal patches containing cannabis for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oral sprays containing cannabis for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; cannabis for medicinal purposes, namely, gummy vitamins for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; cannabis related product, namely, oils for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oils derived from cannabis for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; none of the foregoing containing cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0441: Providing the breeding, growing, cultivation, and harvesting of cannabis for others; production of cannabis, namely, cultivation of cannabis plants, for others; none of the foregoing services featuring or providing cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis
  • DS0000: "MEDICAL"
  • GS0311: Live cannabis plants; Cannabis seeds for agricultural purposes; derived solely from hemp plants containing no more than .3 percent delta-9 tetrahydrocannabinol (THC) concentration by dry weight basis
  • GS0421: Research services, namely, medical, scientific, foods, cosmetic, product, and agricultural research in the area of cannabis, cannabis related products, derivatives of cannabis, and natural health products containing cannabis; none of the foregoing services featuring or providing cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis
Case File Event Statements
  • 8/1/2022 - 2 years ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/31/2022 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 6/3/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/4/2022 - 2 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 8/1/2022 - 2 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/24/2022 - 2 years ago
    6 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/31/2022 - 2 years ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/31/2022 - 2 years ago
    8 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 10/31/2022 - 2 years ago
    9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/25/2023 - 2 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/25/2023 - 2 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/26/2023 - 2 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/19/2023 - 2 years ago
    13 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 5/19/2023 - 2 years ago
    14 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 5/19/2023 - 2 years ago
    15 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 11/16/2023 - a year ago
    16 - SUSPENSION INQUIRY WRITTEN Type: CNSI
  • 11/16/2023 - a year ago
    17 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI
  • 11/16/2023 - a year ago
    18 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2
  • 1/30/2024 - a year ago
    19 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 7/17/2024 - 10 months ago
    22 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/17/2024 - 10 months ago
    21 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/16/2025 - 4 months ago
    26 - SUSPENSION INQUIRY WRITTEN Type: CNSI
  • 1/16/2025 - 4 months ago
    27 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI
  • 1/16/2025 - 4 months ago
    28 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2
  • 7/17/2024 - 10 months ago
    20 - ASSIGNED TO LIE Type: ALIE
  • 7/18/2024 - 10 months ago
    24 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 7/18/2024 - 10 months ago
    23 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 7/18/2024 - 10 months ago
    25 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 4/3/2025 - a month ago
    29 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 4/4/2025 - a month ago
    30 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/4/2025 - a month ago
    32 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 4/4/2025 - a month ago
    34 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 4/4/2025 - a month ago
    33 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 4/4/2025 - a month ago
    31 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME